Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2

Abstract We investigated the clinical and genetic features of patients with severe phenotype of granular corneal dystrophy type 2 (GCD2) associated with compound heterozygosity in the transforming growth factor-β-induced (TGFBI) gene. Patients with severe GCD2 underwent ophthalmic examination (best-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ikhyun Jun, Yong Woo Ji, Seung-il Choi, Bo Ram Lee, Ji Sang Min, Eung Kweon Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8b718696abfc43ab9552600f5aead0be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8b718696abfc43ab9552600f5aead0be
record_format dspace
spelling oai:doaj.org-article:8b718696abfc43ab9552600f5aead0be2021-12-02T14:02:54ZCompound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 210.1038/s41598-021-86414-92045-2322https://doaj.org/article/8b718696abfc43ab9552600f5aead0be2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86414-9https://doaj.org/toc/2045-2322Abstract We investigated the clinical and genetic features of patients with severe phenotype of granular corneal dystrophy type 2 (GCD2) associated with compound heterozygosity in the transforming growth factor-β-induced (TGFBI) gene. Patients with severe GCD2 underwent ophthalmic examination (best-corrected visual acuity test, intraocular pressure measurement, slit-lamp examination, and slit-lamp photograph analysis) and direct Sanger sequencing of whole-TGFBI. The patient’s family was tested to determine the pedigrees. Five novel mutations (p.(His174Asp), p.(Ile247Asn), p.(Tyr88Cys), p.(Arg257Pro), and p.(Tyr468*)) and two known mutations (p.(Asn544Ser) and p.(Arg179*)) in TGFBI were identified, along with p.(Arg124His), in the patients. Trans-phase of TGFBI second mutations was confirmed by pedigree analysis. Multiple, extensive discoid granular, and increased linear deposits were observed in the probands carrying p.(Arg124His) and other nonsense mutations. Some patients who had undergone phototherapeutic keratectomy experienced rapid recurrence (p.(Ile247Asn) and p.(Asn544Ser)); however, the cornea was well-maintained in a patient who underwent deep anterior lamellar keratoplasty (p.(Ile247Asn)). Thus, compound heterozygosity of TGFBI is associated with the phenotypic variability of TGFBI corneal dystrophies, suggesting that identifying TGFBI second mutations may be vital in patients with extraordinarily severe phenotypes. Our findings indicate the necessity for a more precise observation of genotype–phenotype correlation and additional care when treating TGFBI corneal dystrophies.Ikhyun JunYong Woo JiSeung-il ChoiBo Ram LeeJi Sang MinEung Kweon KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ikhyun Jun
Yong Woo Ji
Seung-il Choi
Bo Ram Lee
Ji Sang Min
Eung Kweon Kim
Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2
description Abstract We investigated the clinical and genetic features of patients with severe phenotype of granular corneal dystrophy type 2 (GCD2) associated with compound heterozygosity in the transforming growth factor-β-induced (TGFBI) gene. Patients with severe GCD2 underwent ophthalmic examination (best-corrected visual acuity test, intraocular pressure measurement, slit-lamp examination, and slit-lamp photograph analysis) and direct Sanger sequencing of whole-TGFBI. The patient’s family was tested to determine the pedigrees. Five novel mutations (p.(His174Asp), p.(Ile247Asn), p.(Tyr88Cys), p.(Arg257Pro), and p.(Tyr468*)) and two known mutations (p.(Asn544Ser) and p.(Arg179*)) in TGFBI were identified, along with p.(Arg124His), in the patients. Trans-phase of TGFBI second mutations was confirmed by pedigree analysis. Multiple, extensive discoid granular, and increased linear deposits were observed in the probands carrying p.(Arg124His) and other nonsense mutations. Some patients who had undergone phototherapeutic keratectomy experienced rapid recurrence (p.(Ile247Asn) and p.(Asn544Ser)); however, the cornea was well-maintained in a patient who underwent deep anterior lamellar keratoplasty (p.(Ile247Asn)). Thus, compound heterozygosity of TGFBI is associated with the phenotypic variability of TGFBI corneal dystrophies, suggesting that identifying TGFBI second mutations may be vital in patients with extraordinarily severe phenotypes. Our findings indicate the necessity for a more precise observation of genotype–phenotype correlation and additional care when treating TGFBI corneal dystrophies.
format article
author Ikhyun Jun
Yong Woo Ji
Seung-il Choi
Bo Ram Lee
Ji Sang Min
Eung Kweon Kim
author_facet Ikhyun Jun
Yong Woo Ji
Seung-il Choi
Bo Ram Lee
Ji Sang Min
Eung Kweon Kim
author_sort Ikhyun Jun
title Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2
title_short Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2
title_full Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2
title_fullStr Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2
title_full_unstemmed Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2
title_sort compound heterozygous mutations in tgfbi cause a severe phenotype of granular corneal dystrophy type 2
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8b718696abfc43ab9552600f5aead0be
work_keys_str_mv AT ikhyunjun compoundheterozygousmutationsintgfbicauseaseverephenotypeofgranularcornealdystrophytype2
AT yongwooji compoundheterozygousmutationsintgfbicauseaseverephenotypeofgranularcornealdystrophytype2
AT seungilchoi compoundheterozygousmutationsintgfbicauseaseverephenotypeofgranularcornealdystrophytype2
AT boramlee compoundheterozygousmutationsintgfbicauseaseverephenotypeofgranularcornealdystrophytype2
AT jisangmin compoundheterozygousmutationsintgfbicauseaseverephenotypeofgranularcornealdystrophytype2
AT eungkweonkim compoundheterozygousmutationsintgfbicauseaseverephenotypeofgranularcornealdystrophytype2
_version_ 1718392092827320320